Skip to content

Point of Care Ultrasonography

Influence of Point of Care Ultrasonography on Outcome of Inpatients Admitted To the Internal Ward

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02436317
Enrollment
60
Registered
2015-05-06
Start date
2015-07-19
Completion date
2019-07-31
Last updated
2019-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Abnormalities, Hemodynamic Instability, Respiratory Abnormalities

Keywords

Point Of Care Ultrasonography, Soroka University Medical Center, Heart Failure, cardiovascular

Brief summary

This is a Prospective, Double-center, randomized clinical trial. The purpose of the trial is to evaluate the benefit of adding POC US to the management of inpatients admitted to the internal ward with respiratory, cardiovascular or hemodynamic abnormalities.

Detailed description

This is a Prospective, Double-center, randomized clinical trial. The purpose of the trial is to evaluate the benefit of adding POC US to the management of inpatients admitted to the internal ward with respiratory, cardiovascular or hemodynamic abnormalities. This is a stage 1 pilot trial aimed to provide better understanding on the study population and study groups. This trial will comprise a total of 60 patients, 30 subjects on the intervention group and an equal number on the control group. The results of this pilot trial will be to design a larger trial and calculate a required sample size.

Interventions

DEVICEPoint Of Care Ultrasound

Examination with an ultrasound machine

Sponsors

Soroka University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients admitted to internal ward 2. Age ≥ 18 3. No previous internal ward admission within the last 6 months 4. At least one symptom or sign of the following on admission: * Respiratory abnormalities: Dyspnea, RR\>20, O2 SAT\<90% requirement of oxygen or non-invasive ventilation or mechanical ventilation * Cardiovascular abnormalities: Chest pain, HR\>100, new/worsening peripheral edema, newly diagnosed ECG changes * Hemodynamic instability: SBP\<90 mmHg or on vasopressor infusion or pre-renal azotemia

Exclusion criteria

1. Patients with cognitive impairment or cannot sign informed consent. 2. Subject enrolled in a different study 3. Patients with end stage disease receiving Palliative/end of life treatments. 4. Pregnant patients. 5. Patients that were given a consult by one of the research members pre enrollment 6. Patient under responsibility of one of the study team members

Design outcomes

Primary

MeasureTime frame
Length of hospitalization1 month

Secondary

MeasureTime frame
Readmission rates15 months

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026